• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者肠黏膜通透性与预后的相关性

[Correlation between intestinal mucosal permeability and prognosis in patients with liver cirrhosis].

作者信息

Lian X X, Sun Y P, Guo X X

机构信息

Shanxi University of Traditional Chinese Medicine, Taiyuan 030024, China.

Institute of Chinese Medicine in Shanxi Province, Taiyuan 030012, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):58-63. doi: 10.3760/cma.j.issn.1007-3418.2020.01.014.

DOI:10.3760/cma.j.issn.1007-3418.2020.01.014
PMID:32023701
Abstract

To investigate the correlation between changes in intestinal mucosal permeability and prognosis of patients with liver cirrhosis. Data of 89 cases with liver cirrhosis who were hospitalized in the Hepatology Department of Shanxi Provincial Hospital of Traditional Chinese Medicine from January 2017 to August 2017 were collected as the liver cirrhosis experimental group, and 40 healthy subjects were randomly selected as the healthy control group. JY-DLT, the Intestinal Mucosal Barrier Biochemical Index Analysis System was used to measure the levels of serum diamine oxidase (DAO), D-lactic acid, and endotoxin (ETX) in two groups to evaluate intestinal mucosal barrier function. Spearman's rank correlation test was used to evaluate the correlation between liver cirrhosis prognosis and intestinal mucosal permeability. The results of the two groups were compared by Mann-Whitney H test of two independent samples. One-way Anova was used for intergroup comparison. The pairwise comparison between groups was performed using the LSD or SNK test. The level of ETX in patients with decompensated cirrhosis was significantly higher than that in the compensated phase, and the difference was statistically significant ( < 0.05). The levels of DAO, D-lactic acid and ETX in the liver cirrhosis group were significantly higher than those in the healthy control group, and the differences were statistically significant ( < 0.01). The plasma levels of DAO, D-lactic acid and ETX in the Child-Pugh grade groups of patients with liver cirrhosis were significantly higher than those in the healthy control group, and the differences were statistically significant ( < 0.05). The results of intergroup comparison showed that there were statistically significant differences in DAO, D-lactic acid and ETX levels between Child-Pugh grade A and grade B groups ( = -4.255, 2.527, -2.179, < 0.05). Furthermore, there were statistically significant differences in the levels of D-lactic acid and ETX between the Child-Pugh grade A and grade C groups ( = -2.693, -4.248, < 0.01).The plasma levels of DAO, D-lactic acid and ETX levels were positively correlated ( = 0.205, 0.372, 0.342, < 0.01). D-lactic acid and ETX levels were positively correlated with CTP score, Forns' index, RPR index, APRI score, FIB-4 index and FibroScan score( < 0.01). The three indices (plasma DAO, D-lactic acid, and ETX) can accurately detect the changes in intestinal mucosal permeability. Moreover, the higher index of intestinal mucosal permeability causes the more severe degree of liver cirrhosis and the correlation between the intestinal mucosal permeability and the prognosis score of liver cirrhosis provides a reference for a new evaluation system and new ideas for the treatment of liver cirrhosis.

摘要

探讨肝硬化患者肠黏膜通透性变化与预后的相关性。收集2017年1月至2017年8月在山西省中医院肝病科住院的89例肝硬化患者资料作为肝硬化实验组,随机选取40例健康受试者作为健康对照组。采用JY-DLT肠黏膜屏障生化指标分析系统检测两组血清二胺氧化酶(DAO)、D-乳酸和内毒素(ETX)水平,以评估肠黏膜屏障功能。采用Spearman等级相关检验评估肝硬化预后与肠黏膜通透性的相关性。两组结果采用两独立样本的Mann-Whitney H检验进行比较。组间比较采用单因素方差分析。组间两两比较采用LSD或SNK检验。失代偿期肝硬化患者ETX水平显著高于代偿期,差异有统计学意义(<0.05)。肝硬化组DAO、D-乳酸和ETX水平显著高于健康对照组,差异有统计学意义(<0.01)。肝硬化患者Child-Pugh分级组血浆DAO、D-乳酸和ETX水平显著高于健康对照组,差异有统计学意义(<0.05)。组间比较结果显示,Child-Pugh A级和B级组之间DAO、D-乳酸和ETX水平有统计学差异(=-4.255,2.527,-2.179,<0.05)。此外,Child-Pugh A级和C级组之间D-乳酸和ETX水平有统计学差异(=-2.693,-4.248,<0.01)。血浆DAO、D-乳酸和ETX水平呈正相关(=0.205,0.372,0.342,<0.01)。D-乳酸和ETX水平与CTP评分、Forns指数、RPR指数、APRI评分、FIB-4指数和FibroScan评分呈正相关(<0.01)。这三个指标(血浆DAO、D-乳酸和ETX)可准确检测肠黏膜通透性变化。此外,肠黏膜通透性指标越高,肝硬化程度越严重,肠黏膜通透性与肝硬化预后评分的相关性为新的评估体系提供了参考,为肝硬化治疗提供了新思路。

相似文献

1
[Correlation between intestinal mucosal permeability and prognosis in patients with liver cirrhosis].肝硬化患者肠黏膜通透性与预后的相关性
Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):58-63. doi: 10.3760/cma.j.issn.1007-3418.2020.01.014.
2
Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.肝硬化患者血浆D(-)-乳酸、二胺氧化酶及内毒素的变化
Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):58-61.
3
Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate.通过检测血浆内毒素和二胺氧化酶评估大剂量甲氨蝶呤治疗的急性淋巴细胞白血病患儿的肠道通透性
Anticancer Agents Med Chem. 2016;16(3):387-92. doi: 10.2174/1871520615666150812125955.
4
Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis.血浆二胺氧化酶水平可预测乙型肝炎病毒相关失代偿性肝硬化患者 6 个月的再入院率。
Virol J. 2019 Sep 18;16(1):115. doi: 10.1186/s12985-019-1219-4.
5
[Changes of intestinal mucosal barrier function and effects of early enteral nutrition in patients with severe organophosphorus poisoning].[重度有机磷中毒患者肠道黏膜屏障功能变化及早期肠内营养的影响]
Zhonghua Yi Xue Za Zhi. 2019 Feb 12;99(6):442-446. doi: 10.3760/cma.j.issn.0376-2491.2019.06.012.
6
Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker.评估化疗诱导的黏膜屏障功能障碍的生物标志物:寻找一种快速简便的生物标志物。
Clin Lab. 2015;61(3-4):371-8. doi: 10.7754/clin.lab.2014.140712.
7
[Clinical significance on serum intestinal fatty acid binding protein and D-lactic acid levels in early intestinal injury of patients with sepsis].[血清肠脂肪酸结合蛋白和D-乳酸水平在脓毒症患者早期肠道损伤中的临床意义]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):545-550. doi: 10.3760/cma.j.issn.2095-4352.2019.05.005.
8
Intra-abdominal infection combined with intra-abdominal hypertension aggravates the intestinal mucosal barrier dysfunction.腹腔感染合并腹腔高压加重肠黏膜屏障功能障碍。
Biosci Rep. 2018 Jan 10;38(1). doi: 10.1042/BSR20170931. Print 2018 Feb 28.
9
Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis.肝硬化患者的肠黏膜增殖、凋亡和氧化应激。
Ann Hepatol. 2013 Mar-Apr;12(2):301-7.
10
The preliminary experimental and clinical study of the relationship between the pigment gallstone and intestinal mucosal barrier.色素性胆结石与肠黏膜屏障关系的初步实验与临床研究
J Gastroenterol Hepatol. 2009 Aug;24(8):1451-6. doi: 10.1111/j.1440-1746.2009.05842.x. Epub 2009 Apr 13.

引用本文的文献

1
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis.可溶性髓系细胞触发受体-1作为细菌移位的生物标志物及肝硬化患者益生菌使用指征
World J Hepatol. 2024 May 27;16(5):822-831. doi: 10.4254/wjh.v16.i5.822.
2
Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis.肝硬化患者的肠道微生物群与肠道屏障损伤的生物标志物
Microorganisms. 2024 Feb 25;12(3):463. doi: 10.3390/microorganisms12030463.
3
Efficacy and Safety of a Probiotic Containing CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study.
含CNCM I-745的益生菌治疗失代偿期肝硬化小肠细菌过度生长的疗效与安全性:随机、安慰剂对照研究
J Clin Med. 2024 Feb 5;13(3):919. doi: 10.3390/jcm13030919.
4
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis.肠道微生物群和细菌易位在肝纤维化发病机制中的作用。
Int J Mol Sci. 2023 Nov 19;24(22):16502. doi: 10.3390/ijms242216502.
5
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota.肝硬化相关的肌肉减少症:针对肠道微生物群的治疗前景。
World J Gastroenterol. 2023 Jul 21;29(27):4236-4251. doi: 10.3748/wjg.v29.i27.4236.
6
Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?肝硬化中的肠-肝轴:血流动力学变化是缺失的环节吗?
World J Clin Cases. 2021 Nov 6;9(31):9320-9332. doi: 10.12998/wjcc.v9.i31.9320.